Improved PFS in Advanced Kidney Cancer With Antiangiogenic Combination

By News Health
2 months Ago

(MedPage Today) — SAN FRANCISCO — Dual antiangiogenic therapy for previously treated kidney cancer significantly improved progression-free survival (PFS) versus a single drug, a large randomized trial showed.
Median PFS improved from 10.7…

Source link : https://www.medpagetoday.com/meetingcoverage/ascogu/120094

Author :

Publish date : 2026-02-28 15:00:00

Copyright for syndicated content belongs to the linked Source.

Categories: Health News

Related Content

Unregulated Peptides Pose Dangers to Patients

Diabetes Before Pregnancy May Affect Kids’ Brain Development

Tattooing Linked to Lymphoma and Skin Cancer Risk

Calls for Reformer Pilates regulation amid boom

Smart underwear detects lactose intolerance by tracking your farts

Baveno Criteria May Reduce Endoscopy Burden in Cirrhosis